RTW Investments LP Reduces Position in OraSure Technologies, Inc. (OSUR)

RTW Investments LP decreased its holdings in OraSure Technologies, Inc. (NASDAQ:OSUR) by 8.9% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 535,707 shares of the medical instruments supplier’s stock after selling 52,549 shares during the quarter. OraSure Technologies accounts for about 2.1% of RTW Investments LP’s investment portfolio, making the stock its 14th largest position. RTW Investments LP owned approximately 0.88% of OraSure Technologies worth $12,053,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. State Street Corp boosted its holdings in shares of OraSure Technologies by 6.9% in the second quarter. State Street Corp now owns 1,639,620 shares of the medical instruments supplier’s stock worth $28,305,000 after buying an additional 106,326 shares during the last quarter. Federated Investors Inc. PA boosted its holdings in shares of OraSure Technologies by 505.6% in the second quarter. Federated Investors Inc. PA now owns 312,595 shares of the medical instruments supplier’s stock worth $5,395,000 after buying an additional 260,977 shares during the last quarter. USA Financial Portformulas Corp boosted its holdings in shares of OraSure Technologies by 31.0% in the second quarter. USA Financial Portformulas Corp now owns 56,653 shares of the medical instruments supplier’s stock worth $978,000 after buying an additional 13,421 shares during the last quarter. Chicago Equity Partners LLC boosted its holdings in shares of OraSure Technologies by 38.3% in the second quarter. Chicago Equity Partners LLC now owns 78,430 shares of the medical instruments supplier’s stock worth $1,354,000 after buying an additional 21,730 shares during the last quarter. Finally, 361 Capital LLC boosted its holdings in shares of OraSure Technologies by 59.9% in the second quarter. 361 Capital LLC now owns 26,974 shares of the medical instruments supplier’s stock worth $466,000 after buying an additional 10,107 shares during the last quarter. 94.48% of the stock is currently owned by institutional investors.

Several brokerages have weighed in on OSUR. Zacks Investment Research downgraded shares of OraSure Technologies from a “buy” rating to a “hold” rating in a report on Saturday, November 4th. Jefferies Group reaffirmed a “buy” rating and set a $23.00 price target on shares of OraSure Technologies in a report on Friday, October 20th. ValuEngine downgraded shares of OraSure Technologies from a “buy” rating to a “hold” rating in a report on Thursday, November 2nd. Finally, Canaccord Genuity reaffirmed a “buy” rating and set a $22.00 price target on shares of OraSure Technologies in a report on Tuesday, September 19th. Four equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus target price of $18.21.

OraSure Technologies, Inc. (NASDAQ OSUR) opened at $16.44 on Wednesday. OraSure Technologies, Inc. has a 1-year low of $8.39 and a 1-year high of $23.01. The firm has a market cap of $1,011.61, a P/E ratio of 32.08, a price-to-earnings-growth ratio of 3.20 and a beta of 1.28.

OraSure Technologies (NASDAQ:OSUR) last issued its quarterly earnings results on Wednesday, November 1st. The medical instruments supplier reported $0.09 earnings per share for the quarter, meeting the consensus estimate of $0.09. OraSure Technologies had a net margin of 20.48% and a return on equity of 14.12%. The business had revenue of $42.30 million for the quarter, compared to the consensus estimate of $40.87 million. During the same quarter in the previous year, the firm earned $0.11 earnings per share. The company’s revenue for the quarter was up 31.0% on a year-over-year basis. analysts predict that OraSure Technologies, Inc. will post 0.42 earnings per share for the current fiscal year.

In other news, CEO Douglas A. Michels sold 22,923 shares of OraSure Technologies stock in a transaction that occurred on Wednesday, October 4th. The shares were sold at an average price of $23.00, for a total transaction of $527,229.00. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO Douglas A. Michels sold 25,000 shares of OraSure Technologies stock in a transaction that occurred on Friday, September 29th. The shares were sold at an average price of $22.55, for a total transaction of $563,750.00. Following the sale, the chief executive officer now owns 743,058 shares in the company, valued at approximately $16,755,957.90. The disclosure for this sale can be found here. Company insiders own 6.40% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This article was originally published by Community Financial News and is the property of of Community Financial News. If you are reading this article on another website, it was stolen and republished in violation of international copyright laws. The correct version of this article can be accessed at https://www.com-unik.info/2017/12/06/rtw-investments-lp-reduces-position-in-orasure-technologies-inc-osur.html.

OraSure Technologies Profile

OraSure Technologies, Inc (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types.

Institutional Ownership by Quarter for OraSure Technologies (NASDAQ:OSUR)

What are top analysts saying about OraSure Technologies Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for OraSure Technologies Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit